$FNCH
Finch Therapeutics Group, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022024152 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $8.000K $138.0K $11.34M
YoY Change -99.01% -98.78% 540.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.94M $9.584M $5.739M
YoY Change 115.91% 67.0% 104.45%
% of Gross Profit
Research & Development $16.58M $11.86M $15.54M
YoY Change 12.01% -23.67% 71.77%
% of Gross Profit
Depreciation & Amortization $1.408M $1.405M $638.0K
YoY Change 107.67% 120.22% 211.22%
% of Gross Profit
Operating Expenses $27.52M $40.77M $21.28M
YoY Change 38.5% 91.62% 79.51%
Operating Profit -$40.63M -$9.933M
YoY Change 309.06% -1.47%
Interest Expense $259.0K $45.00K $8.000K
YoY Change 3137.5% 462.5% -214.29%
% of Operating Profit
Other Income/Expense, Net $486.0K $261.0K -$22.00K
YoY Change -1775.86% -1286.36% 144.44%
Pretax Income -$27.01M -$40.37M -$9.955M
YoY Change 41.74% 305.53% -1.34%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.01M -$40.37M -$9.955M
YoY Change 41.74% 305.53% -1.34%
Net Earnings / Revenue -337600.0% -29254.35% -87.76%
Basic Earnings Per Share -$0.85 -$0.21
Diluted Earnings Per Share -$0.56 -$0.85 -$209.8K
COMMON SHARES
Basic Shares Outstanding 47.90M 47.69M 47.45M
Diluted Shares Outstanding 47.73M 47.45M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.04M $85.29M $149.2M
YoY Change -46.78% -42.83%
Cash & Equivalents $71.00M $85.30M $149.2M
Short-Term Investments
Other Short-Term Assets $3.369M $5.324M $4.568M
YoY Change -60.72% 16.55%
Inventory
Prepaid Expenses
Receivables $100.0K $0.00 $2.399M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $74.55M $90.62M $156.2M
YoY Change -47.7% -41.97%
LONG-TERM ASSETS
Property, Plant & Equipment $15.94M $17.28M $19.55M
YoY Change -18.84% -11.59%
Goodwill $0.00 $0.00 $18.06M
YoY Change -100.0% -100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.232M $4.249M $4.041M
YoY Change -13.72% 5.15%
Total Long-Term Assets $88.39M $97.35M $76.81M
YoY Change 6.73% 26.74%
TOTAL ASSETS
Total Short-Term Assets $74.55M $90.62M $156.2M
Total Long-Term Assets $88.39M $97.35M $76.81M
Total Assets $162.9M $188.0M $233.0M
YoY Change -27.7% -19.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.097M $1.060M $1.382M
YoY Change -70.64% -23.3%
Accrued Expenses $13.59M $12.75M $7.469M
YoY Change 22.97% 70.68%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.69M $13.81M $8.851M
YoY Change -0.68% 56.0%
LONG-TERM LIABILITIES
Long-Term Debt $14.65M $14.64M $0.00
YoY Change
Other Long-Term Liabilities $170.0K $125.0K $174.0K
YoY Change 2328.57% -28.16%
Total Long-Term Liabilities $14.82M $14.76M $174.0K
YoY Change 211657.14% 8383.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.69M $13.81M $8.851M
Total Long-Term Liabilities $14.82M $14.76M $174.0K
Total Liabilities $67.23M $67.10M $13.18M
YoY Change 190.46% 409.2%
SHAREHOLDERS EQUITY
Retained Earnings -$275.6M -$248.6M -$141.9M
YoY Change 71.19% 75.17%
Common Stock $371.4M $369.5M $361.7M
YoY Change 2.24% 2.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $95.71M $120.9M $219.8M
YoY Change
Total Liabilities & Shareholders Equity $162.9M $188.0M $233.0M
YoY Change -27.7% -19.32%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$27.01M -$40.37M -$9.955M
YoY Change 41.74% 305.53% -1.34%
Depreciation, Depletion And Amortization $1.408M $1.405M $638.0K
YoY Change 107.67% 120.22% 211.22%
Cash From Operating Activities -$14.27M -$19.09M -$14.35M
YoY Change 3.52% 33.06% 107.55%
INVESTING ACTIVITIES
Capital Expenditures $51.00K -$328.0K -$2.364M
YoY Change -102.55% -86.13% 989.4%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$51.00K -$328.0K -$2.364M
YoY Change -97.45% -86.13% 989.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.00K 41.00K 45.00K
YoY Change -25.71% -8.89% -99.95%
NET CHANGE
Cash From Operating Activities -14.27M -19.09M -14.35M
Cash From Investing Activities -51.00K -328.0K -2.364M
Cash From Financing Activities 52.00K 41.00K 45.00K
Net Change In Cash -14.27M -19.38M -16.67M
YoY Change -9.21% 16.27% -120.14%
FREE CASH FLOW
Cash From Operating Activities -$14.27M -$19.09M -$14.35M
Capital Expenditures $51.00K -$328.0K -$2.364M
Free Cash Flow -$14.32M -$18.77M -$11.99M
YoY Change 21.54% 56.57% 78.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001733257
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40227
dei Entity Registrant Name
EntityRegistrantName
FINCH THERAPEUTICS GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3433558
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Inner Belt Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Somerville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02143
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
229-6499
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
FNCH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47897675
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85292000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
133481000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
494000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5324000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8576000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
90616000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
142551000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17280000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19635000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40355000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5053000
CY2022Q3 fnch In Process Research And Development
InProcessResearchAndDevelopment
32900000
CY2021Q4 fnch In Process Research And Development
InProcessResearchAndDevelopment
32900000
CY2022Q3 us-gaap Goodwill
Goodwill
0
CY2021Q4 us-gaap Goodwill
Goodwill
18057000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2568000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2268000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4249000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4905000
CY2022Q3 us-gaap Assets
Assets
187968000
CY2021Q4 us-gaap Assets
Assets
225369000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1060000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3737000
CY2022Q3 fnch Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10107000
CY2021Q4 fnch Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
9925000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2641000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1128000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
1270000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13808000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14790000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3461000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3461000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14636000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35072000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4887000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
125000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7000
CY2022Q3 us-gaap Liabilities
Liabilities
67102000
CY2021Q4 us-gaap Liabilities
Liabilities
23145000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47826506
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47826506
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47512182
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47512182
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
48000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
47000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
369451000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
363172000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-248633000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160995000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
120866000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202224000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187968000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225369000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
138000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11343000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17726000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11859000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15537000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41312000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42476000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9584000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5739000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27152000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16173000
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
18057000
CY2021Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
18057000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
2173000
us-gaap Restructuring Charges
RestructuringCharges
0
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
40770000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
21276000
us-gaap Operating Expenses
OperatingExpenses
88694000
us-gaap Operating Expenses
OperatingExpenses
58649000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40632000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9933000
us-gaap Operating Income Loss
OperatingIncomeLoss
-87841000
us-gaap Operating Income Loss
OperatingIncomeLoss
-40923000
CY2022Q3 fnch Gains Losses On Extinguishment Of Debt Includes Accrued Interest
GainsLossesOnExtinguishmentOfDebtIncludesAccruedInterest
0
CY2021Q3 fnch Gains Losses On Extinguishment Of Debt Includes Accrued Interest
GainsLossesOnExtinguishmentOfDebtIncludesAccruedInterest
0
fnch Gains Losses On Extinguishment Of Debt Includes Accrued Interest
GainsLossesOnExtinguishmentOfDebtIncludesAccruedInterest
0
fnch Gains Losses On Extinguishment Of Debt Includes Accrued Interest
GainsLossesOnExtinguishmentOfDebtIncludesAccruedInterest
1827000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
45000
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
8000
us-gaap Investment Income Net
InvestmentIncomeNet
-7000
us-gaap Investment Income Net
InvestmentIncomeNet
14000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
28000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
216000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
216000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
261000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
203000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1818000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40371000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9955000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87638000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39105000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-40371000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9955000
us-gaap Net Income Loss
NetIncomeLoss
-87638000
us-gaap Net Income Loss
NetIncomeLoss
-39105000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-40371000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9955000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-87638000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-39105000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47728130
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47728130
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47445195
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47445195
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47611872
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47611872
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36408506
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36408506
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-95718000
CY2021Q1 fnch Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockUponInitialPublicOffering
233053000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
115714000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
335000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13981000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
239457000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3003000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
905000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15169000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
228193000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1515000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9955000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
219801000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202224000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2120000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24567000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
179791000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
110000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1830000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-22700000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
159092000
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2101000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-40371000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
120866000
us-gaap Profit Loss
ProfitLoss
-87638000
us-gaap Profit Loss
ProfitLoss
-39105000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4099000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1623000
us-gaap Share Based Compensation
ShareBasedCompensation
6051000
us-gaap Share Based Compensation
ShareBasedCompensation
2755000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18057000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1808000
fnch Non Cash Interest Expense
NonCashInterestExpense
105000
fnch Non Cash Interest Expense
NonCashInterestExpense
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
28000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1898000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
674000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-494000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1365000
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-61000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4484000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-791000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-656000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3824000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2296000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1297000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
189000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2811000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
50000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
fnch Increase Decrease In Due To Related Parties Current Excluding Accounts Payable
IncreaseDecreaseInDueToRelatedPartiesCurrentExcludingAccountsPayable
0
fnch Increase Decrease In Due To Related Parties Current Excluding Accounts Payable
IncreaseDecreaseInDueToRelatedPartiesCurrentExcludingAccountsPayable
-266000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13630000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2234000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-738000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60579000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53346000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2131000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13981000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
62000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2131000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13919000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
118575000
fnch Proceeds From Underwriters Exercise Of Overallotment Option Net Of Underwriting Discounts And Commissions And Initial Public Offering Costs
ProceedsFromUnderwritersExerciseOfOverallotmentOptionNetOfUnderwritingDiscountsAndCommissionsAndInitialPublicOfferingCosts
0
fnch Proceeds From Underwriters Exercise Of Overallotment Option Net Of Underwriting Discounts And Commissions And Initial Public Offering Costs
ProceedsFromUnderwritersExerciseOfOverallotmentOptionNetOfUnderwritingDiscountsAndCommissionsAndInitialPublicOfferingCosts
3049000
fnch Principal Payments On Capital Lease Obligation
PrincipalPaymentsOnCapitalLeaseObligation
14000
fnch Principal Payments On Capital Lease Obligation
PrincipalPaymentsOnCapitalLeaseObligation
25000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
229000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
14738000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
132000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2659000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14821000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119040000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47889000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51775000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
135965000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99909000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88076000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
151684000
us-gaap Interest Paid Net
InterestPaidNet
407000
us-gaap Interest Paid Net
InterestPaidNet
7000
fnch Payments For Proceeds From Operating Lease Liabilities
PaymentsForProceedsFromOperatingLeaseLiabilities
809000
fnch Payments For Proceeds From Operating Lease Liabilities
PaymentsForProceedsFromOperatingLeaseLiabilities
-1064000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
218000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Stock Issued1
StockIssued1
233053000
fnch Operating Right Of Use Assets Obtained In Exchange For New Operating Leases Upon Adoption Of Asc842
OperatingRightOfUseAssetsObtainedInExchangeForNewOperatingLeasesUponAdoptionOfAsc842
0
fnch Operating Right Of Use Assets Obtained In Exchange For New Operating Leases Upon Adoption Of Asc842
OperatingRightOfUseAssetsObtainedInExchangeForNewOperatingLeasesUponAdoptionOfAsc842
5965000
fnch Remeasurement Of Right Of Use Asset
RemeasurementOfRightOfUseAsset
106000
fnch Remeasurement Of Right Of Use Asset
RemeasurementOfRightOfUseAsset
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
37094000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
fnch Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
7736000
fnch Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
824000
fnch Forgiveness Of Ppp Loan
ForgivenessOfPppLoan
0
fnch Forgiveness Of Ppp Loan
ForgivenessOfPppLoan
1808000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85292000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149200000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2784000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2484000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88076000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
151684000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85300000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
18100000
CY2022Q3 fnch Transfers Between Fair Value Levels
TransfersBetweenFairValueLevels
0
CY2021Q4 fnch Transfers Between Fair Value Levels
TransfersBetweenFairValueLevels
0
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25601000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23861000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8321000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4226000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17280000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19635000
us-gaap Depreciation
Depreciation
4100000
us-gaap Depreciation
Depreciation
1600000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5800000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
900000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5900000
CY2022Q3 fnch Derecognition Of Deferred Rent Liabilities
DerecognitionOfDeferredRentLiabilities
800000
CY2022Q3 fnch Unamortization Of Lease Incentives
UnamortizationOfLeaseIncentives
200000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5300000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5200000
CY2021Q3 fnch Derecognition Of Deferred Rent Liabilities
DerecognitionOfDeferredRentLiabilities
700000
CY2021Q3 fnch Unamortization Of Lease Incentives
UnamortizationOfLeaseIncentives
200000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
700000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-700000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
1100000
fnch Operating Right Of Use Assets Obtained In Exchange For New Operating Leases Upon Adoption Of Asc842
OperatingRightOfUseAssetsObtainedInExchangeForNewOperatingLeasesUponAdoptionOfAsc842
6000000.0
CY2015Q4 fnch Lessee Operating Lease Leases Area
LesseeOperatingLeaseLeasesArea
25785
CY2021Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The lease term is from March 2021 through February 2023
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P2Y
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40355000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5053000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
22000
CY2022Q3 fnch Lease Assets
LeaseAssets
40360000
CY2021Q4 fnch Lease Assets
LeaseAssets
5075000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2641000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1128000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35072000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4887000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
7000
CY2022Q3 fnch Lease Liabilities
LeaseLiabilities
37724000
CY2021Q4 fnch Lease Liabilities
LeaseLiabilities
6041000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
4000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
25000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1724000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
435000
us-gaap Operating Lease Cost
OperatingLeaseCost
3374000
us-gaap Operating Lease Cost
OperatingLeaseCost
1122000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
157000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
25000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
481000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
131000
us-gaap Variable Lease Cost
VariableLeaseCost
1445000
us-gaap Variable Lease Cost
VariableLeaseCost
271000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
216000
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
9000
us-gaap Sublease Income
SubleaseIncome
216000
us-gaap Sublease Income
SubleaseIncome
79000
CY2022Q3 us-gaap Lease Cost
LeaseCost
2011000
CY2021Q3 us-gaap Lease Cost
LeaseCost
574000
us-gaap Lease Cost
LeaseCost
4778000
us-gaap Lease Cost
LeaseCost
1371000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.306
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.306
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2234000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-738000
fnch Principal Payments On Capital Lease Obligation
PrincipalPaymentsOnCapitalLeaseObligation
14000
fnch Principal Payments On Capital Lease Obligation
PrincipalPaymentsOnCapitalLeaseObligation
25000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1065000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
12000
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due Current
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueCurrent
1077000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
6103000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
0
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due In Two Years
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueInTwoYears
6103000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6255000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
0
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due In Three Years
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueInThreeYears
6255000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6427000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
0
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due In Four Years
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueInFourYears
6427000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6187000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due In Five Years
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueInFiveYears
6187000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
27605000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due Thereafter
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDueThereafter
27605000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
53642000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
12000
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Due
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsDue
53654000
CY2022Q3 fnch Interest Portion Of Operating Leases Future Minimum Payments Due
InterestPortionOfOperatingLeasesFutureMinimumPaymentsDue
-15929000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
1000
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Interest Included In Payments
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsInterestIncludedInPayments
-15930000
CY2022Q3 fnch Present Value Of Future Minimum Lease Payments
PresentValueOfFutureMinimumLeasePayments
37713000
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
11000
CY2022Q3 fnch Operating And Finance Lease Obligation Future Minimum Payments Present Value Of Net Minimum Payments
OperatingAndFinanceLeaseObligationFutureMinimumPaymentsPresentValueOfNetMinimumPayments
37724000
CY2022Q3 fnch Accrued Research And Development
AccruedResearchAndDevelopment
907000
CY2021Q4 fnch Accrued Research And Development
AccruedResearchAndDevelopment
1345000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5087000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1117000
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2553000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4401000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1560000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3062000
CY2022Q3 fnch Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10107000
CY2021Q4 fnch Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
9925000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
574000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7210000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7216000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
15000000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
1300000
us-gaap Restructuring Charges
RestructuringCharges
2200000
CY2022Q3 us-gaap Restructuring Costs
RestructuringCosts
300000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-40371000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9955000
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each share of common stock entitles the holder to one vote
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4591264
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3309965
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
500000
us-gaap Net Income Loss
NetIncomeLoss
-87638000
us-gaap Net Income Loss
NetIncomeLoss
-39105000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40371000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2101000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1515000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6051000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2755000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9955000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87638000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39105000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47728130
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47728130
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47445195
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47445195
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47611872
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47611872
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36408506
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36408506
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4591264
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3191715

Files In Submission

Name View Source Status
0000950170-22-024152-index-headers.html Edgar Link pending
0000950170-22-024152-index.html Edgar Link pending
0000950170-22-024152.txt Edgar Link pending
0000950170-22-024152-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fnch-20220930.htm Edgar Link pending
fnch-20220930.xsd Edgar Link pending
fnch-ex10_1.htm Edgar Link pending
fnch-ex31_1.htm Edgar Link pending
fnch-ex31_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fnch-20220930_pre.xml Edgar Link unprocessable
fnch-20220930_lab.xml Edgar Link unprocessable
fnch-20220930_cal.xml Edgar Link unprocessable
fnch-20220930_htm.xml Edgar Link completed
fnch-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fnch-20220930_def.xml Edgar Link unprocessable